Skip to main content

ZNF771 Antibody

Novus Biologicals, part of Bio-Techne | Catalog # NBP2-88737

Novus Biologicals, part of Bio-Techne
Catalog #
Availability
Size / Price
Qty
Loading...
NBP2-88737

Key Product Details

Species Reactivity

Human

Applications

Western Blot

Label

Unconjugated

Antibody Source

Polyclonal Rabbit

Concentration

0.5 mg/ml

Product Specifications

Immunogen

The immunogen is a synthetic peptide directed towards the N-terminal region of human ZNF771. Peptide sequence: EVVKLKIPMDNKEVPGEAPAPSADPARPHACPDCGRAFARRSTLAKHART The peptide sequence for this immunogen was taken from within the described region.

Clonality

Polyclonal

Host

Rabbit

Scientific Data Images for ZNF771 Antibody

Western Blot: ZNF771 Antibody [NBP2-88737]

Western Blot: ZNF771 Antibody [NBP2-88737]

Western Blot: ZNF771 Antibody [NBP2-88737] - WB Suggested Anti-ZNF771 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: Human Thymus

Applications for ZNF771 Antibody

Application
Recommended Usage

Western Blot

1.0 ug/ml

Formulation, Preparation, and Storage

Purification

Affinity purified

Formulation

PBS, 2% Sucrose

Preservative

0.09% Sodium Azide

Concentration

0.5 mg/ml

Shipping

The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.

Stability & Storage

Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.

Background: ZNF771

ZNF771 may be involved in transcriptional regulation

Alternate Names

DSC43, Mesenchymal stem cell protein DSC43, zinc finger protein 771

Gene Symbol

ZNF771

Additional ZNF771 Products

Product Documents for ZNF771 Antibody

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot number in the search box below.

Product Specific Notices for ZNF771 Antibody

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.

Loading...
Loading...
Loading...
Loading...